The company is focused on the discovery, development and commercialization of monoclonal antibodies
MediaPharma has established the Scientific Advisory Board
October 9, 2009
MediaPharma announced today that it has established a Scientific Advisory Board and has appointed four outstanding scientists to form the nucleus of this advisory body. Members of MediaPharma's Scientific Advisory Board include:
Fabio Malavasi
Professor of Medical Genetics at the University of Turin Medical School, Turin, Italy;
Giampaolo Tortora
Professor of Medical Oncology and Head of the Clinical Unit and the Laboratories of Molecular Cancer Therapy at the Medical School of the University of Naples Federico II, Naples, Italy;
Silvia Trasciatti
Director of the Research & Development Division in Abiogen Pharma, Pisa, Italy;
Axel Ullrich
Director of the Department of Molecular Biology at the Max-Planck Institute of Biochemistry, Martinsried, Germany
Tag Cloud
Subscribe to Rss Feed
ShareMediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
